Prognostic value of quantitative measurement of EGFR mutation using peptide nucleic acid clamping in advanced EGFR mutant non‐small cell lung cancer patients

Prognostic value of quantitative measurement of EGFR mutation using peptide nucleic acid clamping in advanced EGFR mutant non‐small cell lung cancer patients

Background The presence of EGFR mutation in patients with advanced non‐small cell lung cancer (NSCLC) plays an important role in determining the appropriate treatment, response, and survival. Therefore, this study attempted to predict the prognosis of NSCLC patients using data from quantitative muta...

Full description

Bibliographic Details
Main Authors: Insu Kim, Jung Seop Eom, Eun Jung Jo, Jeongha Mok.Ki Uk, Kwangha Lee, Ki Uk Kim, Hye‐Kyung Park, Min Ki Lee, Mi‐Hyun Kim
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Thoracic Cancer
Subjects:
Epidermal growth factor receptor
lung cancer
molecular targeted therapy
peptide nucleic acid
prognosis
Online Access:https://doi.org/10.1111/1759-7714.13101

Internet

https://doi.org/10.1111/1759-7714.13101

Similar Items